Di Maio, M., G. Daniele, and M. Piccirillo. “Impact on Health-Related Quality of Life of the Addition of Bevacizumab to First-Line Chemotherapy for Ovarian Cancer:  ”. Cancer Breaking News, vol. 1, no. 1, Oct. 2013, pp. 33-35, https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/254.